The FDA has finalized the new CBE rule. (That’s the so-called “Change Being Effected” rule at 21 C.F.R. Sec. 314.70(c)(6) for drugs.)

Here was our post on that subject when the FDA proposed the rule in January. (We explain there why this change is a big deal.)